tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (DE:GHD)
:GHD
Germany Market

Brainstorm Cell Therapeutics (GHD) Stock Investors

Compare
1 Followers
Based on 804,828 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DE:GHD
On average, investors allocate 0.00% of their portfolios to DE:GHD
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 804,828 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GHD

3.4%
Last 7
Days
18.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:GHD, out of 804,828 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GHD Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of investors who made their portfolios public
The table shows changes in GHD in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GHD Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.69%
-0.33%
-1.89%
2.92B
Healthcare
DraftKings
4.30%
-0.75%
+4.54%
36.03B
Consumer Cyclical
Nio
7.51%
-0.59%
-0.48%
7.08B
Consumer Cyclical
Lucid Group
5.15%
+0.96%
+1.32%
6.68B
Consumer Cyclical
Marathon Digital Holdings
4.71%
+0.25%
+0.64%
5.04B
Financial
Bristol Myers
3.07%
-0.21%
+0.41%
95.36B
Healthcare
Riot Platforms
4.55%
+0.05%
-0.23%
3.42B
Financial
Sirius XM Holdings
3.10%
-0.97%
-3.28%
7.35B
Communication Services
Ford Motor
5.35%
-0.71%
-1.21%
42.11B
Consumer Cyclical
CVS Health
4.00%
-0.51%
-1.35%
84.21B
Healthcare
Based on the activity of 804,828 active portfolios
Open your Smart Portfolio

GHD Investor Analysis

DE:GHD investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.4%
of DE:GHD holders
are under 35
Average Segment Performance
Average P/E Ratio22.51
Beta4.61
Dividend Yield3.98%
DE:GHD investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.8%
of DE:GHD holders
are between 35–55
Average Segment Performance
Average P/E Ratio17.46
Beta11.43
Dividend Yield3.45%
DE:GHD investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.8%
of DE:GHD holders
are over 55
Average Segment Performance
Average P/E Ratio15.12
Beta4.52
Dividend Yield3.61%
Overview of age group and performance of DE:GHD stock investors
See who invests in GHD according to age group and performance.

FAQ

How many retail Investors hold DE:GHD?
<0.1% of TipRanks' retail investors hold DE:GHD in their portfolios.
    What is DE:GHD Investor Sentiment?
    DE:GHD’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of DE:GHD in the last 7 days?
      ▲ 3.4% of TipRanks' retail investors changed their holding of DE:GHD in the last 7 days.
        What percentage of retail investors changed their holding of DE:GHD in the last 30 days?
        ▲ 18.0% of TipRanks' retail investors changed their holding of DE:GHD in the last 30 days.
          What is the average age of retail investors who hold DE:GHD?
          The average age of DE:GHD Holders is between 35–55.
            What other stocks have DE:GHD investors also bought?
            DE:GHD Investors also bought VKTX, DKNG, NIO, LCID, MARA, BMY, RIOT, SIRI, F, CVS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis